Coronary stents are the first varieties carried out after the state launched the procurement of high-value medical consumables. On January 1, 2021, the centralized procurement of coronary stents organized by the state was implemented. Many cardiovascular doctors, including Lv Weihui, director of the cardiovascular department of Ershadao Hospital of the Provincial Hospital of Traditional Chinese Medicine, still remember this detail: "The average price of a coronary stent has dropped from 10,000 to 3 yuan." The heart stent, which once cost tens of thousands of yuan, entered the era of 100 yuan.
In the past, patients with coronary heart disease needed surgery, and some had to put two stents, and the cost of light materials was close to 30,000 yuan, and the total cost of surgery would make some patients with poor economic conditions give up surgery. Since the establishment of centralized procurement, a few hundred cardiac coronary stents are enough, and there are almost no patients who have given up surgery for economic reasons in recent years. "Having been engaged in clinical practice for many years, Lu Weihui is quite impressed by this change.
Six brackets on the body.
The two hospitalizations before and after felt different.
Mr. Wang, 80 years old, has nearly 61 years of writing experience and is a well-known writer in Guangzhou. Over the years, Mr. Wang has worked tirelessly, and two well-documented diaries were found at the scene, and Mr. Wang told reporters the story of two heart surgeries in recent years.
May 2019Suffering from the long-blocked coronary artery could not be opened, Mr. Wang was very depressed. When I participated in a free clinic activity, I met Dr. Lu Weihui by chance. In view of Mr. Wang's complex condition, Dr. Lui Weihui's team successfully performed coronary stent surgery for him. With five stents implanted and a new lease on life, Mr. Wang is very grateful to the team of doctors.
After the operation, I picked up the medical list and saw that this rejuvenated operation cost a lot: the material cost was more than 160,000 yuan, and the stent needed 1150,000 yuan, an average of 2 per bracket30,000 yuan.
For this operation, Mr. Wang said that because he knew that the stents needed for the operation were relatively expensive, he went to the bank twice, first went to the Industrial and Commercial Bank of China to transfer 90,000 yuan of the salary passbook to the bank card, and then went to the CCB to deposit 30,000 yuan of the salary passbook into the bank card, and prepared a hospitalization deposit of 120,000 yuan for the operation in advance.
End of 2022Because of the new blockage of the coronary artery in the heart, Mr. Wang performed coronary stent surgery again and implanted a sixth stent. This time, the centralized procurement of cardiac coronary stents was implemented, which was already very cheap, so Mr. Wang did not go to the bank to prepare a deposit for hospitalization. At the end of the operation, I looked at the cost list, and the contrast was very strong: out of the material cost of 20,000 yuan, the cost of the drug-coated stent was only a few hundred yuan.
Patients no longer give up on surgery because they are worried about the cost.
Comparing the experience of the two surgeries in 2019 and 2022, Mr. Wang, as an individual, is experiencing great changes brought about by the centralized procurement of pharmaceutical consumables.
Coronary stents are the first varieties carried out after the state launched the procurement of high-value medical consumables. On January 1, 2021, after the implementation of centralized procurement of coronary stents, a coronary stent was reduced from more than 10,000 yuan to less than 800 yuan.
In the past, when cardiac stents were more expensive, we often needed to spend some energy and time to communicate with patients about the cost. Lu Weihui still clearly remembers that many years ago, there was a Yunfu man who was engaged in courier delivery work, and was sent to the hospital because of cardiac arrest, and the imaging data showed that his heart and blood vessels were in poor condition and needed coronary stent surgery. "At that time, the patient's family was only 1With a deposit of about 30,000 yuan, we estimate that two stents need to be implanted for the operation, and the stent fee is expected to be 260,000 yuan, the overall operation cost needs about 5-60,000 yuan. Faced with this shortfall, the patient's family is in a desperate situation of raising money. The team of doctors performed an emergency coronary stent surgery on the patient, and the patient was in a very stable condition after the operation.
After the centralized procurement of medicines and equipment began, Lu Weihui said franklyIn recent years, patients who need stent surgery have basically given up surgery due to financial reasons。As a clinician, "in the past, we needed to estimate the cost, and it took a certain amount of time and energy to explain the medical expenses when communicating with the patient, but now the patient's financial concerns have been greatly dispelled, the communication between the doctor team and the patient is smoother, and the two sides have focused on the disease assessment, diagnosis and treatment plan, and surgical risks, and the communication is more effective, and in the case of reduced medical costs, the patient can afford more medical services within the economic range, which will help to improve the efficacy of the operation." ”
Unleash the benefits of the people and improve the temperature of people's livelihood.
The story of coronary stents is just a microcosm of the new changes in the collection of medicines and devices in the past five years. In the past five years, Guangzhou GPO (Guangzhou Pharmaceutical and Medical Consumables Group Procurement) has organized and implemented a total of 36 batches of national, provincial and municipal centralized procurement, covering 989 kinds of drugs such as hypertension, diabetes, anti-tumor, antiviral, etc., as well as 31 types of medical consumables such as coronary stents, coronary balloons, artificial joints, intraocular lenses, oral implants, staplers, and punctures, and promoted a large number of first-class medical devices such as "sky-high drugs", "10,000 yuan dental implants" and "10,000 yuan stents" to "fly into ordinary people's homes".
In April 2019, the procurement platform of Guangzhou Pharmaceutical Group was fully launched, and in October of the following year, the Guangzhou medical consumables procurement trading platform was put into operation. By the end of 2023, the Guangzhou platform will provide drug and medical consumables procurement and trading services for more than 2,900 medical institutions in 19 cities in the province, and the platform will have more than 2660,000 and more than 3 million medical consumables, and the drug transaction amount ranks first in the province.
In 2019, Guangzhou began to implement group procurement, and compared with Guangzhou before the comprehensive reform of public medical institutions in 2017, the overall cost reduction of GPO drugs in Guangzhou was about 2522%, which can save about 4.2 billion yuan in drug procurement costs that year. Organize two batches of five types of municipal medical consumables alliance group with volume procurement, the average price reduction of coronary guide catheters and guide wires is more than 33%, the average price reduction of tubular end and hemorrhoidal stapler is more than 85%, and the average price reduction of the puncture device is more than 85%, and the results of centralized procurement of the trocar are promoted and implemented in all cities in the province.
Behind the price reduction data, it is the result of the cooperation of many parties, which has become a real "gift package" in the patient group and improved the temperature of people's livelihood.
* |Guangzhou Medical Insurance.
Edit |Zhang Chenxuan bought Xiaofei.
Hot Article
Is the use of test methods by hospitals inconsistent with the connotation of the project, which is a medical insurance violation?
In 2024, where is volume procurement headed? Many places have reported the results of medical insurance flight inspections in 2023: problems such as excessive standard charges and excessive inspections are frequent